Description

Accelerate your science at Chiesi's 2024 Pharma Day ®. 

MassBio’s Pharma Days are unparalleled opportunities for emerging innovators to learn from and connect with world-leading biopharmaceutical companies. 

DISCOVER 

Join Chiesi's open information session for the latest insights on its R&D strategy, target therapeutic areas, and partnering capabilities. A networking reception will follow this session. 

Chiesi's target therapeutic areas within rare diseases are: 

• Hematology
• Immunology
• Dermatology
• Ophthalmology
• Endo-metabolic
• Inborn errors of metabolism 
• Respiratory 

ABOUT CHIESI 

Chiesi Global Rare Diseases is a business unit of the Chiesi Group, a family business striving to create a world where it is common to have a therapy for all diseases and acting as a force for good, for society and the planet. Global Rare Diseases was founded in February 2020 and based in Boston, established to deliver innovative therapies and solutions for people living with rare diseases and is working to ensure access to treatments, no matter how rare the condition, so as many people as possible can experience their most fulfilling life. The unit collaborates with the rare disease community around the globe to bring voice to underserved people in the health care system. For more information, please visit chiesirarediseases.com 

This is a partnering event focused on science and innovation. No solicitations.

REGISTER NOW